Testing effectiveness (Phase 2)UnknownNCT00108875
What this trial is testing
Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer
Who this might be right for
Malignant MelanomaPancreatic CancerColon Cancer+1 more
Julius-Maximilians University 70